Reply to thread

Message: [QUOTE="greenmedinfo, post: 1940"] PMID: Biomedicines. 2021 Nov 13 ;9(11). Epub 2021 Nov 13. PMID: 34829912 Abstract Title: Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox. Abstract: Fibromyalgia (FM) is a chronic condition characterized by persistent widespread pain that negatively affects the quality of life of patients. The WNT/β-catenin signaling pathway seems to be involved in central sensitization and different pain states. The objective of this study was to investigate the beneficial effects of a new compound called Hidrox(HD), containing 40-50% hydroxytyrosol, in counteracting the pain associated with FM. An FM-like model was induced in rats by subcutaneous injections of reserpine (1 mg/kg) for three consecutive days. Later, HD (10 mg/kg) was administered orally to the animals for seven days. Reserpine injections induced WNT/β-catenin pathway activation, release of pro-inflammatory mediators as well as a significant increase in oxidative stress. Daily treatment with HD was able to modulate the WNT/β-catenin and Nrf2 pathways and consequently attenuate the behavioral deficits and microglia activation induced by reserpine injection. These results indicate that nutritional consumption of HD can be considered as a new therapeutic approach for human FM. [URL='https://www.greenmedinfo.com/article/these-results-indicate-nutritional-consumption-hidrox-can-be-considered-new-th']read more[/URL] [/QUOTE]